Delivery Order SPE2DB20D3303-SPE2DB23FA0JT
Award Date 8/4/23
Potential Completion Date 8/7/23
Potential Value $20K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $24,095.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD and other federal agencies. Performance will take place in Conshohocken, Pennsylvania from August 16-17, 2023. No subcontractors or set aside designations were identified. The award supports DLA's...
- The Defense Logistics Agency awarded a $6,715.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The delivery order was issued against an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from July 14 to July 17, 2023. No subcontractors or set aside designations were identified. This delivery order supports...
- The Defense Logistics Agency awarded a $29,171.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 28, 2023. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a $20,272 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML SYRINGEML. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 2, 2023. The order was placed under an existing DLA contract vehicle to support the agency's medical supply needs. No set aside designation or subcontractors were identified in the...
- The Defense Logistics Agency awarded a $6,715.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The delivery order was issued against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a three-day period from September 22 through September 25, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $7,336.64 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The delivery order was issued against an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from August 30 to August 31, 2023. No subcontractors or set aside designations were identified. This delivery order supports...
- The Defense Logistics Agency awarded a $13,547 delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania through August 28, 2023 to support DLA programs. No subcontractors or set aside designations were identified. STELARA is a biologic medication used to treat autoimmune diseases such as plaque psoriasis and inflammatory bowel disease. This award draws upon...
- The Defense Logistics Agency awarded a $100,735.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the STELARA syringes to a facility in Conshohocken, Pennsylvania by September 28, 2023. No subcontractors or set aside designations were identified. This...
- The Defense Logistics Agency awarded a $35,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The delivery order was issued against an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from August 4-7, 2023. No subcontractors or set aside designations were identified. This delivery order supports DLA's mission to...
- The Defense Logistics Agency awarded a $6,715.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML SYRINGEML. The prime contractor, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill agency requirements between August 24-25, 2023. No subcontractors or set aside designations were indicated. The award is consistent with DLA's mission to provide medical supplies...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB23FA0JTDelivery Order
The Defense Logistics Agency awarded a $20,239 delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania through August 7, 2023 to support DLA programs. No subcontractors or set aside designations were specified. The award draws from DLA's indefinite-delivery/indefinite-quantity pharmaceutical prime vendor contract vehicle to provide rheumatoid arthritis medication for DOD beneficiaries.
Generated 12/23/23, 3:48 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.2k | 8/4/23 |